Arrowhead Pharmaceuticals Inc. (ARWR) at a glance

Arrowhead Pharmaceuticals Inc. (ARWR) is a large-cap Healthcare company. It trades at $82.79, with a P/E of 47.1, a -48.4% profit margin and revenue decline of 86.4%. It does not pay a dividend. Vestovix scores it 26/100 overall. Its strongest dimension is Momentum (74/100) and its weakest is Value (1/100). Its volatility is roughly in line with the market.

Price

$82.79

Market cap

$10.50B

P/E ratio

47.1

Dividend yield

None

Beta

1.27

52-week range

$21.61 to $95.49